Literature DB >> 19006257

A modified "preclosure" technique after percutaneous aortic valve replacement.

Philipp Kahlert1, Holger Eggebrecht, Raimund Erbel, Stefan Sack.   

Abstract

OBJECTIVES: To evaluate the feasibility, safety and efficacy of suture-mediated closure devices using a modified "preclosure" technique for access site management after percutaneous aortic valve replacement (PAVR).
BACKGROUND: PAVR using a retrograde transfemoral approach has recently evolved to an endovascular alternative to open surgery in high-risk patients. However, large-bore femoral artery access is required, commonly demanding surgical closure and general anesthesia. A truly percutaneous intervention would be desirable to reduce procedural complexity and diminish the need of vascular surgery and general anaesthesia.
METHODS: After direct puncture of the common femoral artery, three conventional suture-mediated closure devices (6F Perclose) were deployed. The preloaded sutures were tied at the end of the procedure. If no immediate hemostasis was achieved, an additional device was deployed thereafter.
RESULTS: PAVR with percutaneous access site closure was attempted in 15 consecutive patients and could successfully be achieved in all patients allowing conscious sedation in all but three cases. Following complications occurred: one retroperitoneal bleeding caused by removal of the valve delivery sheath requiring surgical repair, as well as two cases of femoral and iliac artery dissection caused by delivery sheath introduction and treated by stenting and vascular surgery, respectively. Vascular surgery became only necessary due to total vessel occlusion after suture closure and remains the only closure-related complication. However, treatment led to recovery in all patients.
CONCLUSIONS: The modified "preclosure" technique is a feasible and safe method for hemostasis after PAVR improving procedural management and diminishing the need for general anesthesia. (c) 2008 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2008        PMID: 19006257     DOI: 10.1002/ccd.21711

Source DB:  PubMed          Journal:  Catheter Cardiovasc Interv        ISSN: 1522-1946            Impact factor:   2.692


  14 in total

Review 1.  Which strategy for a protein crystallization project?

Authors:  C E Kundrot
Journal:  Cell Mol Life Sci       Date:  2004-03       Impact factor: 9.261

2.  [Current status for interventional and surgical aortic valve implantation].

Authors:  Raimund Erbel; Heinz-Günter Jakob
Journal:  Herz       Date:  2009-08       Impact factor: 1.443

Review 3.  Percutaneous management of vascular access in transfemoral transcatheter aortic valve implantation.

Authors:  Ilaria Dato; Francesco Burzotta; Carlo Trani; Filippo Crea; Gian Paolo Ussia
Journal:  World J Cardiol       Date:  2014-08-26

Review 4.  [Decompensated valve failure: the revival of balloon valvuloplasty - percutaneous valve intervention].

Authors:  Stefan Sack; Jochen Menne; Thomas Krüger; Michael Weber; Dieter Müller; Werner Zwehl
Journal:  Herz       Date:  2009-05       Impact factor: 1.443

5.  Vascular access site complications after percutaneous transfemoral aortic valve implantation.

Authors:  Philipp Kahlert; Fadi Al-Rashid; Marcel Weber; Daniel Wendt; Torsten Heine; Eva Kottenberg; Matthias Thielmann; Hilmar Kühl; Jürgen Peters; Heinz G Jakob; Stefan Sack; Raimund Erbel; Holger Eggebrecht
Journal:  Herz       Date:  2009-08       Impact factor: 1.443

Review 6.  [Transcatheter-based aortic valve implantation. Present and future technologies].

Authors:  Stefan Sack; Joachim Schofer
Journal:  Herz       Date:  2009-08       Impact factor: 1.443

Review 7.  The complexity of parathyroid hormone-related protein signalling.

Authors:  E Maioli; V Fortino
Journal:  Cell Mol Life Sci       Date:  2004-02       Impact factor: 9.261

8.  Overcoming the Challenges of the Transfemoral Approach in Transcatheter Aortic Valve Implantation.

Authors:  Stephane Noble; Marco Roffi
Journal:  Interv Cardiol       Date:  2013-08

9.  Urochordates carry multiple genes for goose-type lysozyme and no genes for chicken- or invertebrate-type lysozymes.

Authors:  I W Nilsen; B Myrnes; R B Edvardsen; D Chourrout
Journal:  Cell Mol Life Sci       Date:  2003-10       Impact factor: 9.261

10.  Comparison of early clinical outcomes following transcatheter aortic valve implantation versus surgical aortic valve replacement versus optimal medical therapy in patients older than 80 years with symptomatic severe aortic stenosis.

Authors:  Eui Im; Myeong-Ki Hong; Young-Guk Ko; Dong-Ho Shin; Jung-Sun Kim; Byeong-Keuk Kim; Donghoon Choi; Chi Young Shim; Hyuk-Jae Chang; Jae-Kwang Shim; Young-Lan Kwak; Sak Lee; Byung-Chul Chang; Yangsoo Jang
Journal:  Yonsei Med J       Date:  2013-05-01       Impact factor: 2.759

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.